AstraZeneca

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. 

CEO
Pascal Soriot
CEOPascal Soriot
Employees
96,100
Employees96,100
Headquarters
Cambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded
1913
Founded1913
Employees
96,100
Employees96,100

AZN Key Statistics

Market cap
258.38B
Market cap258.38B
Price-Earnings ratio
24.63
Price-Earnings ratio24.63
Dividend yield
1.89%
Dividend yield1.89%
Average volume
3.64M
Average volume3.64M
High today
$166.46
High today$166.46
Low today
$163.98
Low today$163.98
Open price
$164.57
Open price$164.57
Volume
1.50M
Volume1.50M
52 Week high
$212.71
52 Week high$212.71
52 Week low
$145.79
52 Week low$145.79

Stock Snapshot

As of today, AstraZeneca(AZN) shares are valued at $166.28. The company's market cap stands at 258.38B, with a P/E ratio of 24.63 and a dividend yield of 1.89%.

On 2026-08-24, AstraZeneca(AZN) stock moved within a range of $163.98 to $166.46. With shares now at $166.28, the stock is trading +1.4% above its intraday low and -0.1% below the session's peak.

Trading activity shows a volume of 1.5M, compared to an average daily volume of 3.64M.

Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $145.79.

Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $145.79.

AZN News

TipRanks 2h
AstraZeneca’s AZD4144 Interaction Study Adds Quiet Support to AZN’s Pipeline Story

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confi...

TipRanks 2h
AstraZeneca Pharma India Discloses Unsolicited ESG Rating from Crisil - TipRanks

...

AstraZeneca Pharma India Discloses Unsolicited ESG Rating from Crisil - TipRanks
TipRanks 9h
AstraZeneca initiated with an Outperform at CICC

CICC analyst Yuan Guo initiated coverage of AstraZeneca (AZN) with an Outperform rating and $198 price target The firm views the company’s pipeline as “excellen...

Analyst ratings

87%

of 31 ratings
Buy
87.1%
Hold
9.7%
Sell
3.2%

More AZN News

The Motley Fool 4d
Kyntra Bio Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. Thursday, Aug. 13, 2026 at 5:00 p.m. ET CALL PARTICIPANTS LifeSci Advisors - Gaia Shamis Chief Executive Officer - Thane Wettig...

Kyntra Bio Q2 2026 Earnings Call Transcript
TipRanks 4d
AstraZeneca’s EMBOLD-Asia Trial Signals Fresh Push Into Obesity Market

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confi...

TipRanks 5d
AstraZeneca Expands Respiratory Pipeline With New China Trial for Chronic Lung Infections

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confi...

TipRanks 5d
AstraZeneca CFO Receives First Vesting Under Long-Term Performance Share Plan

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

TipRanks 6d
AstraZeneca Tracks Real‑World Ultomiris Outcomes in Polish Rare Disease Study

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confi...

TipRanks 6d
AstraZeneca Maps Rare Kidney Disease Burden in Egypt, Opening Doors for Future Growth

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident...

People also own

Based on the portfolios of people who own AZN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.